Closing on Nov. 17: Investor Calendar + Company Spotlight

INVESTOR NETWORK is the go-to, one-stop site for shareholders, clients and prospective investors

TENAX Therapeutics, Inc.

TENAX Therapeutics, Inc.

Sector: Biological Products Except Diagnostic Substances Region: NC, United States

: | Nasdaq: TENX

Similar to: Inovio Pharmaceuticals, Inc., Bebra Biogas Holding AG

Tenax Therapeutics is a specialty pharmaceutical company focused on identifying, developing and commercializing a portfolio of products for the critical care market.

Our business strategy includes 3 core elements: Search, Develop, and Commercialize

Search: We intend to identify and acquire innovative proprietary pharmaceutical products that represent high value commercial opportunities for the North American market. We do not intend to conduct basic research ourselves. The relative efficiency of our “search” strategy enables us to focus the majority of our resources on developing and commercializing innovative products that other companies have discovered.

Develop: We intend to develop pharmaceutical products that meet significant unmet needs of critical care patients in North America. Our significant clinical development and regulatory experience makes Tenax Therapeutics an ideal partner for companies who lack this expertise, but who want to capitalize on the significant market opportunity that exists in the US and Canada.

Commercialize: We intend to commercialize the products that we in-license and develop. Our substantial experience in launching and growing critical care brands in the US makes us an ideal partner for companies who lack this expertise and capability.

News & Analysis

You may also be interested in: